These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4133645)

  • 21. Preliminary studies on the use of thyrotropin releasing hormone in manic states, depression, and the dysphoria of alcohol withdrawal.
    Huey LY; Janowsky DS; Mandell AJ; Judd LL; Pendery M
    Psychopharmacol Bull; 1975 Jan; 11(1):24-27. PubMed ID: 804705
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Thyrotrophin-releasing hormone in depression.
    Mountjoy CQ; Hall R
    Lancet; 1974 Aug; 2(7877):415. PubMed ID: 4137018
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral protirelin (T.R.H.) in depression.
    Sugerman AA; Swartzburg M; Mueller PS; Rochford J
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):94-8. PubMed ID: 812670
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthetic thyroid releasing hormone (TRH) administered orally to chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    Psychopharmacol Commun; 1975; 1(2):191-200. PubMed ID: 817373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant effect of thyrotropin-releasing hormone (TRH) and the plasma thyrotropin levels in depression.
    Takahashi S; Kondo H; Yoshimura M; Ochi Y
    Folia Psychiatr Neurol Jpn; 1973; 27(4):305-14. PubMed ID: 4205643
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of endogenous depressions with thyrotropin-releasing hormone (TRH) under oral administration.
    Schmidt J
    Acta Psychiatr Scand; 1977 Feb; 55(2):142-6. PubMed ID: 402795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of depression with chlorimipramine (Anafranil)].
    Jovanović UJ; Sattes H
    Med Klin; 1970 Feb; 65(6):260-3. PubMed ID: 5519056
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of thyrotropin releasing hormone (TRH) in normal subjects and in patients with thyroid gland diseases].
    Lauridsen UB; Friis T; Kirkegaard C; Hansen JM; Siersbaek-Nielsen K
    Ugeskr Laeger; 1974 Jun; 136(25):1360-4. PubMed ID: 4210165
    [No Abstract]   [Full Text] [Related]  

  • 29. Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordings.
    Amin MM; Ban TA; Lehmann HE; Marcotte E
    Psychopharmacol Bull; 1978 Jan; 14(1):39-42. PubMed ID: 343149
    [No Abstract]   [Full Text] [Related]  

  • 30. [New therapeutic possiblities in depression: the thyrotropin releasing hormone factor].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias L; Hernández Herreros M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1974 Mar; 2(2):91-102. PubMed ID: 4211532
    [No Abstract]   [Full Text] [Related]  

  • 31. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients.
    Fava M; Rosenbaum JF; Birnbaum R; Kelly K; Otto MW; MacLaughlin R
    Acta Psychiatr Scand; 1992 Jul; 86(1):42-5. PubMed ID: 1414398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preliminary study of the action of thyrotropin releasing hormone (TRH) in depressive states].
    Deniker P; Ginestet D; Lôo H; Zarifian E; Cottereau MJ
    Ann Med Psychol (Paris); 1974 Feb; 1(2):249-55. PubMed ID: 4211567
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chlorimipramine therapy of depressive with special analysis of blood pressure changes during infusions].
    Ose E
    Arzneimittelforschung; 1973 Jun; 23(6):817-23. PubMed ID: 4579950
    [No Abstract]   [Full Text] [Related]  

  • 34. Affective state and thyrotropin and prolactin responses after repeated injections of thyrotropin-releasing hormone in depressed patients.
    Ehrensing RH; Kastin AJ; Schalch DS; Friesen HG; Vargas JR; Schally AV
    Am J Psychiatry; 1974 Jun; 131(6):714-8. PubMed ID: 4208055
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: T.R.H. in psychoses.
    Dimitrikoudi M; Hanson-Norty E; Jenner FA
    Lancet; 1974 Mar; 1(7855):456. PubMed ID: 4131456
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.
    Callahan AM; Frye MA; Marangell LB; George MS; Ketter TA; L'Herrou T; Post RM
    Biol Psychiatry; 1997 Feb; 41(3):264-72. PubMed ID: 9024949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abbott-38579 (synthetic TRH) in the treatment of depression: a controlled study of oral administration.
    Sugerman AA; Mueller PS; Swartzburg M; Rochford J
    Psychopharmacol Bull; 1975 Jan; 11(1):30. PubMed ID: 804708
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyrotropin-releasing hormone in a patient with bipolar disorder.
    Philpot VB
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):349-50. PubMed ID: 8369648
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.
    van der Vis-Melsen MJ; Weiner JD
    Lancet; 1972 Dec; 2(7792):1415. PubMed ID: 4118700
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thyrotropin releasing factor and depressive state: acroagonines of TRH].
    Chazot G; Chalumeau A; Mornex R; Schott B; Girard PF
    Probl Actuels Endocrinol Nutr; 1974; Serie 18():261-71. PubMed ID: 4220114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.